Combination vaccine

16 marketed 45 in Phase 3

This page covers all Combination vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Hepatitis A virus antigen; Hepatitis B surface antigen (HBsAg), Hepatitis B surface antigen; Haemophilus influenzae type b polysaccharide.

Targets

Hepatitis A virus antigen; Hepatitis B surface antigen (HBsAg) · Hepatitis B surface antigen; Haemophilus influenzae type b polysaccharide

Marketed (16)

Phase 3 pipeline (45)